Aorfix

Lombard Medical

Lombard Medical, is a medical device company focused on the $1.8bn market for minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura™ endograft system, an innovative ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies.

News

Altura Endograft System: A unique tool in the endovascular armamentariumem

Altura Endograft System: A unique tool in the endovascular armamentariumem


Endovascular repair presents a safe and effective treatment method, but late failure of endovascular aneurysm repair (EVAR) and endoleak both remain a problem for vascular specialists.
Five-year PYTHAGORAS results with Aorfix stent graft in highly angulated necks

Five-year PYTHAGORAS results with Aorfix stent graft in highly angulated necks

The outcomes at five years of the Aorfix (Lombard Medical) PYTHAGORAS trial, published in the Journal of Vascular Surgery, provided the first long-term data from an endovascular aneurysm repair (EVAR) cohort to include a majority of highly angulated infrarenal necks

Events

Vascular Society for Great Britain and Ireland (VSGBI) Annual Meeting

Vascular Society for Great Britain and Ireland (VSGBI) Annual Meeting

Vascular Society for Great Britain and Ireland (VSGBI) Annual Meeting
27th – 29th November 2019 
German Society of Vascular Surgery (DGG) Annual Meeting

German Society of Vascular Surgery (DGG) Annual Meeting

German Society of Vascular Surgery (DGG) Annual Meeting

16th – 19th October 2019